New England Biolabs

The partnership will allow customers using NEBNext Direct target enrichment products to analyze data with the Bluebee platform.

The two companies will work to characterize new Cas nucleases, and NEB will then manufacture and commercially distribute the nucleases globally.

The services will couple NEB's reagents and expertise in enzyme development and manufacturing with TTP's Desktop Biology product development and engineering know-how.

Researchers outlined the "nicking enzyme-assisted sequencing" (NicE-seq) protocol and presented results from proof-of-principal open chromatin profiling experiments.

This Week in Science

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

The team found that DNA damage affects a variety of samples and may lead to erroneous low-frequency variant calls unless stringent filtering is applied or the damage is repaired prior to sequencing.

The company published the results of an extensive error analysis and plans to use its new high-sensitivity fidelity assay to develop enzymes in the future.

Anna-Sophia Boguraev during her visit to New England Biolabs. Credit: James McNeill

Co-sponsored by Boeing and miniPCR, the winning high school student's project will be carried out by astronauts aboard ISS and is believed to be the first ever PCR in space.

The appeals court agreed with a previous ruling that found New England Biolabs failed to file its lawsuit in a timely manner.

Pages

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.